Demant AS

DEMANT: XCSE (DNK)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
DKK 526.00LwyyrNsdtzzdf

Weakness in Hearing Care and Communications Offsets Good Developments in Hearing Aids for Demant

We are maintaining our fair value estimate of DKK 254 for narrow-moat Demant following the release of first-half results. Management downgraded organic revenue growth for fiscal 2022 from 5%-9% to 4%-6% as a result of lower-than-expected growth for hearing care in the U.S. and continued COVID-19 impacts in the Asia and Pacific regions in the first half. We view shares as fairly valued.

Sponsor Center